Reasoning that expression of mitochondria-targeted estrogen receptors altered sensitivity to endocrine therapy agents and dynamic BH3 profiling response in breast cancer cells, we sought to identify the effect of mitochondrial estrogen receptors on mitochondrial bioenergetics. Here, ESR1 is linked to breast carcinoma.